Vaxart Inc. [NASDAQ: VXRT] stock went on an upward path that rose over 28.43% on Friday, amounting to a one-week price increase of more than 209.23%. The biotechnology company that makes oral vaccines recently announced that its potential COVID-19 vaccine has been picked for the experimental process that will take part during a non-human primate (NHP) challenge study organized and sponsored by Operation Warp Speed. Operation Warp Speed plans to provide a major amount of effective vaccine for U.S. citizens by January 2021.
The vaccine would be experimented on monkeys infected with coronavirus in order to obtain exclusive results. As the world fights with this pandemic, Vaxart remains one of those few companies coming up with a potential vaccine to this disease. With this news, the shares of VXRT have surged and investors bet on drug developers as it might come up with cure to this global pandemic.
Over the last 12 months, VXRT stock rose by 1075.44%. The one-year Vaxart Inc. stock forecast points to a potential downside of -23.69. The average equity rating for VXRT stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $464.39 million, with 60.68 million shares outstanding and 58.60 million shares in the current float. Compared to the average trading volume of 8.84M shares, VXRT stock reached a trading volume of 227172897 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Vaxart Inc. [VXRT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VXRT shares is $6.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VXRT stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Vaxart Inc. is set at 1.00, with the Price to Sales ratio for VXRT stock in the period of the last 12 months amounting to 62.76. The Price to Book ratio for the last quarter was 15.46, with the Price to Cash per share for the same quarter was set at 0.52.
VXRT Stock Performance Analysis:
Vaxart Inc. [VXRT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 209.23. With this latest performance, VXRT shares gained by 203.40% in over the last four-week period, additionally plugging by 2392.25% over the last 6 months – not to mention a rise of 1075.44% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VXRT stock in for the last two-week period is set at 91.59, with the RSI for the last a single of trading hit 95.63, and the three-weeks RSI is set at 86.88 for Vaxart Inc. [VXRT]. The present Moving Average for the last 50 days of trading for this stock 2.91, while it was recorded at 4.56 for the last single week of trading, and 1.36 for the last 200 days.
Insight into Vaxart Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Vaxart Inc. [VXRT] shares currently have an operating margin of -110.17. Vaxart Inc.’s Net Margin is presently recorded at -189.06.
Return on Total Capital for VXRT is now -33.85, given the latest momentum, and Return on Invested Capital for the company is -67.27. Return on Equity for this stock declined to -154.15, with Return on Assets sitting at -51.61. When it comes to the capital structure of this company, Vaxart Inc. [VXRT] has a Total Debt to Total Equity ratio set at 143.95. Additionally, VXRT Total Debt to Total Capital is recorded at 59.01, with Total Debt to Total Assets ending up at 50.35. Long-Term Debt to Equity for the company is recorded at 114.95, with the Long-Term Debt to Total Capital now at 47.12.
Reflecting on the efficiency of the workforce at the company, Vaxart Inc. [VXRT] managed to generate an average of -$1,331,786 per employee. Receivables Turnover for the company is 3.64 with a Total Asset Turnover recorded at a value of 0.27.Vaxart Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.50 and a Current Ratio set at 4.50.
VXRT Stock EPS
With the latest financial reports released by the company, Vaxart Inc. posted -0.39/share EPS, while the average EPS was predicted by analysts to be reported at -0.38/share.When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -2.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VXRT.
Vaxart Inc. [VXRT] Insider Position Details
There are presently around $244 million, or 46.70% of VXRT stock, in the hands of institutional investors. The top three institutional holders of VXRT stocks are: ARMISTICE CAPITAL, LLC with ownership of 25,200,000, which is approximately 0% of the company’s market cap and around 0.20% of the total institutional ownership; RENAISSANCE TECHNOLOGIES LLC, holding 2,173,728 shares of the stock with an approximate value of $17.48 million in VXRT stocks shares; and VANGUARD GROUP INC, currently with $5.18 million in VXRT stock with ownership of nearly 1840.103% of the company’s market capitalization.
Positions in Vaxart Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 28 institutional holders increased their position in Vaxart Inc. [NASDAQ:VXRT] by around 3,650,262 shares. Additionally, 4 investors decreased positions by around 96,637 shares, while 8 investors held positions with 26,649,224 shares. The mentioned changes placed institutional holdings at 30,396,123 shares, according to the latest SEC report filing. VXRT stock had 21 new institutional investments in for a total of 1,420,982 shares, while 2 institutional investors sold positions of 38,810 shares during the same period.